Erratum: Prevalence of type 2 diabetes in Germany in 2040: Estimates from an epidemiological model (European Journal of Epidemiology DOI 10.1007/s10654-012-9726-2);Prevalence of type 2 diabetes in Germany in 2040: Estimates from an epidemiological model

European Journal of Epidemiology

Volumn 27, Issue 10, 2012, Pages 791-797

  Brinks, Ralph ^a   Tamayo, Teresa ^a   Kowall, Bernd ^a   Rathmann, Wolfgang ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Epidemiology; Modelling; Prediabetes; Prediction; Prevention; Type 2 diabetes

Indexed keywords

ADULT; AGED; ARTICLE; EFFECT SIZE; EPIDEMIOLOGICAL DATA; FEMALE; GERMANY; HEALTH PROGRAM; HIDDEN MARKOV MODEL; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREVALENCE; PROPHYLAXIS;

EID: 84871268215     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9731-5     Document Type: Erratum

References (18)

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31-40.
2. Sicree R, Shaw J, Zimmet R. The global burden: Diabetes and impaired glucose tolerance. Background material for the IDF Diabetes Atlas. http://www.idf.org/diabetesatlas/downloads/back groundpapers. Accessed 27 July 2011.
3. US Census Bureau. US Population Projections. http://www.cens us.gov/population/www/projections/index.html. Accessed 27 July 2011.
4. Office for National Statistics. National Population Projections. http://www.statistics.gov.uk/StatBase/Product.asp?vlnk=8519. Accessed 27 July 2011.
5. Federal Statistical Office of Germany. 12. Population Projection [12. Koordinierte Bevolkerungsvorausberechnung]. http://www. destatis.de. Accessed 27 July 2011.
6. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, Khunti K. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: Systematic review and meta-analysis. BMJ. 2007;334 (7588):299.
7. Sonnenberg FA, Beck Jr. Markov models in medical decision making: A practical guide. Med Decis Mak. 1993;13:322-38.
8. Schipf S, Werner A, Tamayo T, Holle R, Schunk M, Maier W, Meisinger C, Thorand B, Berger K, Mueller G, Moebus S, Bokhof B, Kluttig A, Greiser KH, Neuhauser H, Ellert U, Icks A, Rathmann W, Volzke H. Regional differences in the prevalence of known type 2 diabetes mellitus in 45-74 years old individuals: Results from six population-based studies in Germany (DIABCORE Consortium). Diabet Med. 2012;. doi:10.1111/j.1464-5491.2012.03578.x.
9. Rathmann W, Haastert B, Icks A, Lowel H, Meisinger C, Holle R, Giani G. High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000. Diabetologia. 2003;46:182-9.
10. Kowall B, Rathmann W, Heier M, Giani G, Peters A, Thorand B, Huth C, Icks A, Meisinger C. Categories of glucose tolerance and continuous glycemic measures and mortality. Eur J Epidemiol. 2011;26:637-45.
11. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hamalainen H, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: Follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673-9.
12. Evans JMM, Barnett KN, Ogston SA, Morris AD. Increasing prevalence of type 2 diabetes in a Scottish population: Effect of increasing incidence or decreasing mortality? Diabetologia. 2007;50:729-32.
13. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K. The Danish National Diabetes Register: Trends in incidence, prevalence and mortality. Diabetologia. 2008;51:2187-96.
14. Tabák G, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: A high-risk state for diabetes development. Lancet. 2012;379:2279-90.
15. Keiding N, Hansen BE, Holst C. Nonparametric estimation of disease incidence from a cross-sectional sample of a stationary population. Lect Notes Biomath. 1990;86:36-45.
16. Honeycutt AA, Boyle JP, Broglio KR, Thompson TJ, Hoerger TJ, Geiss LS, Narayan KM. A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050. Health Care Manag Sci. 2003;6(3):155-64.
17. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;22(8):29.
18. Baan CA, van Baal PH, Jacobs-van der Bruggen MA, Verkley H, Poos MJ, Hoogenveen RT, Schoemaker CG. Diabetes mellitus in the Netherlands: Estimate of the current disease burden and prognosis for 2025. Ned Tijdschr Geneeskd. 2009;153:A580. (Dutch).